CLINICAL_TRIALS
trial_result
· 2024-01-16
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM) [Phase 1]
Summary
Phase 1 trial of tirzepatide (LY3298176) in healthy participants and individuals with type 2 diabetes mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Healthy, Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED | Results posted: 2024-01-16